213 related articles for article (PubMed ID: 23372669)
21. ETS transcription factor ELF5 induces lumen formation in a 3D model of mammary morphogenesis and its expression is inhibited by Jak2 inhibitor TG101348.
Chean J; Chen CJ; Shively JE
Exp Cell Res; 2017 Oct; 359(1):62-75. PubMed ID: 28800960
[TBL] [Abstract][Full Text] [Related]
22. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
23. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.
Roncero AM; López-Nieva P; Cobos-Fernández MA; Villa-Morales M; González-Sánchez L; López-Lorenzo JL; Llamas P; Ayuso C; Rodríguez-Pinilla SM; Arriba MC; Piris MA; Fernández-Navarro P; Fernández AF; Fraga MF; Santos J; Fernández-Piqueras J
Leukemia; 2016 Jan; 30(1):94-103. PubMed ID: 26216197
[TBL] [Abstract][Full Text] [Related]
24. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
[TBL] [Abstract][Full Text] [Related]
25. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.
Peng HY; Jiang SS; Hsiao JR; Hsiao M; Hsu YM; Wu GH; Chang WM; Chang JY; Jin SL; Shiah SG
Mol Oncol; 2016 Jun; 10(6):895-909. PubMed ID: 27038552
[TBL] [Abstract][Full Text] [Related]
26. Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?
Prochorec-Sobieszek M; Nasiłowska-Adamska B; Borg K; Kopeć I; Kos-Zakrzewska K; Juszczyński P; Warzocha K
Leuk Lymphoma; 2012 Sep; 53(9):1824-7. PubMed ID: 22288769
[No Abstract] [Full Text] [Related]
27. Differential selectivity of JAK2 inhibitors in enzymatic and cellular settings.
Yu V; Pistillo J; Archibeque I; Han Lee J; Sun BC; Schenkel LB; Geuns-Meyer S; Liu L; Emkey R
Exp Hematol; 2013 May; 41(5):491-500. PubMed ID: 23340136
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of cytokine signalling-6 promotes neurite outgrowth via JAK2/STAT5-mediated signalling pathway, involving negative feedback inhibition.
Gupta S; Mishra K; Surolia A; Banerjee K
PLoS One; 2011; 6(11):e26674. PubMed ID: 22125600
[TBL] [Abstract][Full Text] [Related]
29. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.
Sen B; Peng S; Woods DM; Wistuba I; Bell D; El-Naggar AK; Lai SY; Johnson FM
Clin Cancer Res; 2012 Jan; 18(1):127-39. PubMed ID: 22090359
[TBL] [Abstract][Full Text] [Related]
30. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.
Velusamy T; Kiel MJ; Sahasrabuddhe AA; Rolland D; Dixon CA; Bailey NG; Betz BL; Brown NA; Hristov AC; Wilcox RA; Miranda RN; Medeiros LJ; Jeon YK; Inamdar KV; Lim MS; Elenitoba-Johnson KS
Blood; 2014 Dec; 124(25):3768-71. PubMed ID: 25349176
[TBL] [Abstract][Full Text] [Related]
31. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
[TBL] [Abstract][Full Text] [Related]
32. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
Kopp KL; Ralfkiaer U; Gjerdrum LM; Helvad R; Pedersen IH; Litman T; Jønson L; Hagedorn PH; Krejsgaard T; Gniadecki R; Bonefeld CM; Skov L; Geisler C; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
Cell Cycle; 2013 Jun; 12(12):1939-47. PubMed ID: 23676217
[TBL] [Abstract][Full Text] [Related]
33. LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits β-casein synthesis in bovine mammary epithelial cells.
Geng Z; Shan X; Lian S; Wang J; Wu R
Life Sci; 2021 Aug; 278():119547. PubMed ID: 33930363
[TBL] [Abstract][Full Text] [Related]
34. Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.
Huang KP; Chase AJ; Cross NCP; Reiter A; Li TY; Wang TF; Chu SC; Lu XY; Li CC; Kao RH
Int J Hematol; 2008 Sep; 88(2):197-201. PubMed ID: 18594780
[TBL] [Abstract][Full Text] [Related]
35. Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.
Schwaab J; Knut M; Haferlach C; Metzgeroth G; Horny HP; Chase A; Tapper W; Score J; Waghorn K; Naumann N; Jawhar M; Fabarius A; Hofmann WK; Cross NC; Reiter A
Ann Hematol; 2015 Feb; 94(2):233-8. PubMed ID: 25260694
[TBL] [Abstract][Full Text] [Related]
36. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis.
Nihal M; Stutz N; Schmit T; Ahmad N; Wood GS
Cell Cycle; 2011 Apr; 10(8):1303-11. PubMed ID: 21436619
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells.
Sandoval-Usme MC; Umaña-Pérez A; Guerra B; Hernández-Perera O; García-Castellano JM; Fernández-Pérez L; Sánchez-Gómez M
PLoS One; 2014; 9(1):e87769. PubMed ID: 24489959
[TBL] [Abstract][Full Text] [Related]
38. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.
Zhou Y; Zhang Z; Wang N; Chen J; Zhang X; Guo M; John Zhong L; Wang Q
Cell Death Dis; 2018 Apr; 9(4):429. PubMed ID: 29559623
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.
Zhang Q; Wang HY; Wei F; Liu X; Paterson JC; Roy D; Mihova D; Woetmann A; Ptasznik A; Odum N; Schuster SJ; Marafioti T; Riley JL; Wasik MA
J Immunol; 2014 Mar; 192(6):2913-9. PubMed ID: 24523507
[TBL] [Abstract][Full Text] [Related]
40. SOCS2 exacerbates myocardial injury induced by ischemia/reperfusion in diabetic mice and H9c2 cells through inhibiting the JAK-STAT-IGF-1 pathway.
Sheng M; Huang Z; Pan L; Yu M; Yi C; Teng L; He L; Gu C; Xu C; Li J
Life Sci; 2017 Nov; 188():101-109. PubMed ID: 28867579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
